Games Other Content Highlights on selpercatinib in RET-mutant medullary thyroid cancer: The LIBRETTO-531 study Channel: European Society for Medical Oncology (ESMO) • Sourced: European Society for Medical Oncology (ESMO) • Published 9 months ago
